UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 503

Sortiert nach

Mechanisms of echinocandin antifungal drug resistance

Annals of the New York Academy of Sciences, 2015-09, Vol.1354 (1), p.1-11

Perlin, David S.

2015

Volltextzugriff (PDF)

The global problem of antifungal resistance: prevalence, mechanisms, and management

The Lancet infectious diseases, 2017-12, Vol.17 (12), p.e383-e392

2017

Volltextzugriff (PDF)

Echinocandin Resistance, Susceptibility Testing and Prophylaxis: Implications for Patient Management

Drugs (New York, N.Y.), 2014-09, Vol.74 (14), p.1573-1585

Perlin, David S.

2014

Volltextzugriff (PDF)

COVID-19 Associated Pulmonary Aspergillosis (CAPA)-From Immunology to Treatment

Journal of fungi (Basel), 2020-06, Vol.6 (2), p.91

2020

Volltextzugriff (PDF)

Identification of Drug Resistant Candida auris

Frontiers in microbiology, 2019-08, Vol.10, p.1918-1918

2019

Volltextzugriff (PDF)

Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris

Antimicrobial agents and chemotherapy, 2018-06, Vol.62 (6)

2018

Volltextzugriff (PDF)

Rapid and Accurate Molecular Identification of the Emerging Multidrug-Resistant Pathogen Candida auris

Journal of clinical microbiology, 2017-08, Vol.55 (8), p.2445-2452

2017

Volltextzugriff (PDF)

The importance of antimicrobial resistance in medical mycology

Nature communications, 2022-09, Vol.13 (1), p.5352-5352, Article 5352

2022

Volltextzugriff (PDF)

Coping with stress and the emergence of multidrug resistance in fungi

PLoS pathogens, 2015-03, Vol.11 (3), p.e1004668-e1004668

2015

Volltextzugriff (PDF)

Correlating Echinocandin MIC and Kinetic Inhibition of fks1 Mutant Glucan Synthases for Candida albicans: Implications for Interpretive Breakpoints

Antimicrobial Agents and Chemotherapy, 2009-01, Vol.53 (1), p.112-122

2009

Volltextzugriff (PDF)

Rapid and quantitative detection of SARS-CoV-2 specific IgG for convalescent serum evaluation

Biosensors & bioelectronics, 2020-12, Vol.169, p.112572-112572, Article 112572

2020

Volltextzugriff (PDF)

Macrophage internalization creates a multidrug-tolerant fungal persister reservoir and facilitates the emergence of drug resistance

Nature communications, 2023-03, Vol.14 (1), p.1183-1183, Article 1183

2023

Volltextzugriff (PDF)

COVID-19-Associated Candidiasis (CAC): An Underestimated Complication in the Absence of Immunological Predispositions?

Journal of fungi (Basel), 2020-10, Vol.6 (4), p.211

2020

Volltextzugriff (PDF)

Echinocandin Resistance in Candida

Clinical infectious diseases, 2015-12, Vol.61 (suppl_6), p.S612-S617

Perlin, David S.

2015

Volltextzugriff (PDF)

Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance

Nature communications, 2016-03, Vol.7 (1), p.11128-11128, Article 11128

2016

Volltextzugriff (PDF)

Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium

Antibiotics (Basel), 2020-12, Vol.9 (12), p.877

2020

Volltextzugriff (PDF)

Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure

Emerging infectious diseases, 2009-07, Vol.15 (7), p.1068-1076

2009

Volltextzugriff (PDF)

Reactive oxidant species induced by antifungal drugs: identity, origins, functions, and connection to stress-induced cell death

Frontiers in cellular and infection microbiology, 2023-10, Vol.13, p.1276406-1276406

2023

Volltextzugriff (PDF)

Effect of Candida glabrata FKS1 and FKS2 Mutations on Echinocandin Sensitivity and Kinetics of 1,3-β-d-Glucan Synthase: Implication for the Existing Susceptibility Breakpoint

Antimicrobial Agents and Chemotherapy, 2009-09, Vol.53 (9), p.3690-3699

2009

Volltextzugriff (PDF)

Discovery of MRSA active antibiotics using primary sequence from the human microbiome

Nature chemical biology, 2016-12, Vol.12 (12), p.1004

2016

Volltextzugriff (PDF)

Enfumafungin Derivative MK-3118 Shows Increased In Vitro Potency against Clinical Echinocandin-Resistant Candida Species and Aspergillus Species Isolates

Antimicrobial Agents and Chemotherapy, 2014-02, Vol.58 (2), p.1248-1251

2014

Volltextzugriff (PDF)

Review of the Novel Echinocandin Antifungal Rezafungin: Animal Studies and Clinical Data

Journal of fungi (Basel), 2020-09, Vol.6 (4), p.192

2020

Volltextzugriff (PDF)

Requirement for ergosterol in V-ATPase function underlies antifungal activity of azole drugs

PLoS pathogens, 2010-06, Vol.6 (6), p.e1000939

2010

Volltextzugriff (PDF)

A Naturally Occurring Proline-to-Alanine Amino Acid Change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis Accounts for Reduced Echinocandin Susceptibility

Antimicrobial Agents and Chemotherapy, 2008-07, Vol.52 (7), p.2305-2312

2008

Volltextzugriff (PDF)

Randomized, double-blind, controlled trial of human anti-LIGHT monoclonal antibody in COVID-19 acute respiratory distress syndrome

The Journal of clinical investigation, 2022-02, Vol.132 (3), p.1-7

2022

Volltextzugriff (PDF)

1 – 25 von 503

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(462)
Mit Volltextzugriff
(473)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(382)
Life Sciences & Biomedicine
(345)
Microbiology
(224)
Humans
(180)
Antifungal Agents - Pharmacology
(108)
Infectious Diseases
(99)
Biological And Medical Sciences
(96)
Pharmacology & Pharmacy
(96)
Microbial Sensitivity Tests
(83)
Medical Sciences
(75)
Mycology
(75)
Echinocandins
(72)
Antifungal Agents
(69)
Mutation
(68)
Animals
(66)
Female
(64)
Echinocandins - Pharmacology
(61)
Fungal Proteins - Genetics
(52)
Male
(52)
Antifungal Agents - Therapeutic Use
(49)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Mechanisms of echinocandin antifungal drug resistance

The global problem of antifungal resistance: prevalence, mechanisms, and management

Echinocandin Resistance, Susceptibility Testing and Prophylaxis: Implications for Patient Management

COVID-19 Associated Pulmonary Aspergillosis (CAPA)-From Immunology to Treatment

Identification of Drug Resistant Candida auris

Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris

Rapid and Accurate Molecular Identification of the Emerging Multidrug-Resistant Pathogen Candida auris

The importance of antimicrobial resistance in medical mycology

Coping with stress and the emergence of multidrug resistance in fungi

Correlating Echinocandin MIC and Kinetic Inhibition of fks1 Mutant Glucan Synthases for Candida albicans: Implications for Interpretive Breakpoints

Rapid and quantitative detection of SARS-CoV-2 specific IgG for convalescent serum evaluation

Macrophage internalization creates a multidrug-tolerant fungal persister reservoir and facilitates the emergence of drug resistance

COVID-19-Associated Candidiasis (CAC): An Underestimated Complication in the Absence of Immunological Predispositions?

Echinocandin Resistance in Candida

Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance

Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium

Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure

Reactive oxidant species induced by antifungal drugs: identity, origins, functions, and connection to stress-induced cell death

Effect of Candida glabrata FKS1 and FKS2 Mutations on Echinocandin Sensitivity and Kinetics of 1,3-β-d-Glucan Synthase: Implication for the Existing Susceptibility Breakpoint

Discovery of MRSA active antibiotics using primary sequence from the human microbiome

Enfumafungin Derivative MK-3118 Shows Increased In Vitro Potency against Clinical Echinocandin-Resistant Candida Species and Aspergillus Species Isolates

Review of the Novel Echinocandin Antifungal Rezafungin: Animal Studies and Clinical Data

Requirement for ergosterol in V-ATPase function underlies antifungal activity of azole drugs

A Naturally Occurring Proline-to-Alanine Amino Acid Change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis Accounts for Reduced Echinocandin Susceptibility

Randomized, double-blind, controlled trial of human anti-LIGHT monoclonal antibody in COVID-19 acute respiratory distress syndrome

Suchergebnisse filtern